Aurobindo Pharma : Newspaper Advertisements

			MUMBAI | 13 AUGUST 2022	9
.							<

		Kkalpana Industries (India) Limited
			CIN: L19202WB1985PLC039431
		Regd Office: New BK Market, 16A Shakespeare Sarani, 4th Floor, Room No. 3, Kolkata - 700071
			Telephone: [phone]
		E-Mail: [e-mail] Website: www.kkalpanagroup.com
		EXTRACT OF UNAUDITED FINANCIAL RESULTS FOR THE 1ST QUARTER ENDED 30TH JUNE 2022
						Rs. In Lacs (except per share data)
				STANDALONE			CONSOLIDATED
	Sl		Quarter ended	Year ended	Quarter ended	Year ended
	PARTICULARS
	No.	30.06.2022	30.06.2021	31.03.2022	30.06.2022	30.06.2021	31.03.2022
			(Un-audited)(Un-audited)	(Audited)	(Un-audited)(Un-audited)	(Audited)
1	Total Income from Operations	10770.98	606.16	4016.15	10770.98	606.16	4016.15
2	Net Profit/(Loss) for the period (before Tax, Exceptional and /or
		Extraordinary items)	41.17	58.26	287.60	34.74	52.41	261.25
3	Net Profit/(Loss) for the period before Tax, (after Exceptional and /or
		Extraordinary items)	41.17	58.26	287.60	34.74	52.41	261.25
4	Net Profit/(Loss) for the period after Tax, (after Exceptional and /or
		Extraordinary items)	30.19	1.49	529.93	23.76	-4.36	503.58
5	Total comprehensive income for the period (Comprising profit/(loss) for the
		period (after tax) and other comprehensive income (after tax))	30.19	1.49	529.44	23.76	-4.36	503.25
6	Net Profit after Tax and Share of Profit of Subsidiary/ Associate				24.10	-3.41	501.51
7	Equity Share Capital	1881.46	1881.46	1881.46	1881.46	1881.46	1881.46
8	Reserves (excluding Revaluation Reserve) as shown in Audited Balance
		Sheet of the previous year			1482.47			1475.96

9 Earnings per share (of Rs. 2/- each) (for continuing and discontinuing operations)

Basic:	0.03	0.00	0.56	0.03	0.00	0.53
Diluted:	0.03	0.00	0.56	0.03	0.00	0.53

Notes:

1. The above is an extract of the detailed format of Un-audited Financial Results (Standalone & Consolidated) for the 1st quarter ended 30th June 2022 filed with the Stock Exchanges under Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015. The full format of the Un-audited Financial Results (Standalone & Consolidated) for the 1st quarter ended 30th June 2022 are available on the website of BSE Ltd at www.bseindia.com & Calcutta Stock Exchange Limited at www.cse-india.com and that of the Company at www. kkalpanagroup.com
2. The Un-audited Financial Results (Standalone & Consolidated) for the 1st quarter ended 30th June 2022 have been reviewed by the audit committee and have also been approved by the Board of Directors at their respective meeting held on 12th August 2022. The statutory Auditor has given Limited Review Report for the above financial results.
3. The Group is engaged primarily in the business of different grades of plastic granules which constitute single reporting segment. Accordingly, the company is a single segment company in accordance with "Indian Accounting Standards 108 Operating Segment".".
4. The Consolidated Results include Results of :-
5. 1. the company's Wholly Owned Subsidiary Company viz. "Ddev Plastic Ltd."
   2. the company's Wholly Owned foreign Subsidiary Company viz " Kkalpana Plastic Reprocess Industries Middleeast FZE" and
   3. the Associate Company "Kkalpana Plastick Limited" in which the company holds 36.23% of its paid up Equity share capital.
6. The figures for the corresponding previous period has been regrouped/reclassified wherever necessary, to conform to the current period figures and to give impact of accounting adjustment arising pursuant to the scheme of Demerger which has been approved by the Honorable National Company Law Tribunal ("NCLT"), vide its order dated 4th March 2022 with Appointed Date 1st April 2021 and effective from 01st April 2022 on filing with the Registrar of Companies.

	FOR KKALPANA INDUSTRIES (INDIA) LTD
	SD/-
	NARRINDRA SURANNA
Place : Kolkata	CHAIRMAN & MANAGING DIRECTOR
Date: 12th August, 2022	(DIN 00060127)

Continuous Excellence Through Performance

AUROBINDO PHARMA LIMITED

(CIN - L24239TG1986PLC015190)

Regd. Office: Plot No.2, Maithrivihar, Ameerpet, Hyderabad - 500 038, Telangana, India.

Tel: [phone] Fax: [phone] Email: [e-mail]

STATEMENT OF STANDALONE/CONSOLIDATED UNAUDITED FINANCIAL

RESULTS FOR THE QUARTER ENDED 30.06.2022

										(Rs. in millions)
						Standalone			Consolidated
Sr.					Quarter	Year ended	Quarter	Quarter	Year ended	Quarter
	Pa	culars	ended	ended	ended	ended
No.
				30.06.2022	31.03.2022	30.06.2021	30.06.2022	31.03.2022	30.06.2021
					Unaudited	Audited	Unaudited	Unaudited	Audited	Unaudited
1	Total income from opera ons (net)	27,869.2	1,12,871.4	28,937.5	62,359.2	2,34,554.9	57,019.8
2	Net Profit / (Loss) for the period	1,700.7	17,121.9	3,350.5	6,789.9	35,007.1	10,177.1
	(before Tax and Ex	onal items)
3	Net Profit / (Loss) for the period before	1,700.7	16,374.8	3,350.5	6,789.9	33,727.4	10,177.1
	ta	er Ex	onal items)
4	Net Profit / (Loss) for the period a er	1,221.6	14,547.1	2,150.7	5,203.8	26,471.1	7,699.7
	ta	er Ex	onal items)
5	Total Comprehensive income for the	1,225.8	14,564.0	2,134.7	6,974.4	29,087.6	10,013.0
	period [ Comprising Profit/(Loss)
	fo		er tax) and Other
	Compr			er tax)]
6	Paid-up equity Share Capital (face value	585.9	585.9	585.9	585.9	585.9	585.9
	of Re.1/- each)
7	Other equity (excluding Revalua on		1,70,587.5			2,45,173.9
	Reserve) as shown in the Audited
	Balance Sheet
8	Other equity (excluding Revalua on	As on March 31, 2022	As on March 31, 2022
	Reserve) as shown in the Audited		170,587.5			245,173.9
	Balance Sheet of previous year
9	Earnings per share of ₹1/- each	(not annualised)	(annualised)	(not annualised)	(not annualised)	(annualised)	(not annualised)
	(a) Basic (in ₹)			2.08	24.83	3.67	8.88	45.19	13.14
	(b) Diluted (in ₹)			2.08	24.83	3.67	8.88	45.19	13.14

Note: The above is an extract of the detailed format of Quarterly Financial Results filed with the Stock Exchanges under Regulation 33 of SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015. The full format of the Financial Results are available on the Stock Exchanges' web sites viz. www.bseindia.com, www.nseindia.com and on the Company's web site viz. www.aurobindo.com

	By Order of the Board
	Aurobindo Pharma Limited
	Sd/-
Place : Hyderabad	K. Nithyananda Reddy
Date : August 11, 2022	Vice Chairman & Managing Director
	www.aurobindo.com

APOLLO TYRES' REVENUE UP 30% IN THE 1ST QUARTER

EXTRACT OF UNAUDITED CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2022

	Million
QUARTER ENDED	YEAR ENDED

S. No. PARTICULARS

30.06.2022 30.06.2021 31.03.2022

(UNAUDITED)(AUDITED)

1

Total income from operations

59,420.02

45,844.71

209,475.78

• Net profit / (loss) for the period (before tax and

exceptional items)

2,384.58

1,623.03

8,535.82

• Net profit / (loss) for the period before tax (after

exceptional items)

2,384.58

1,613.57

8,476.74

• Net profit / (loss) for the period after tax (after exceptional

items)

1,906.81

1,277.88

6,386.00

• Total comprehensive income for the period [comprising profit / (loss) for the period (after tax) and other

	comprehensive income (after tax)]	(1,065.74)	3,611.40	5,312.86
6	Paid up equity share capital (equity shares of 1 each)	635.10	635.10	635.10
7	Reserves excluding revaluation reserves			116,855.00
8	Securities premium account	31,317.67	31,317.67	31,317.67
9	Net worth	116,455.58	118,042.71	117,521.32
10	Paid up debt capital	18,173.14	20,712.72	19,671.21
11	Outstanding redeemable preference shares	-	-	-
12	Debt equity ratio (in times)	0.51	0.58	0.53

13 Earnings per share (of 1 each) (not annualised):

	Basic ( )	3.00	2.01	10.06
	Diluted ( )	3.00	2.01	10.06
14	Capital redemption reserve	44.40	44.40	44.40
15	Debenture redemption reserve	1,039.50	1,039.50	1,039.50
16	Debt service coverage ratio (in times) #	1.08	3.13	1.14
17	Interest service coverage ratio (in times)	5.23	4.82	4.96

# Based on TTM (Trailing Twelve Months)

Notes:

1. The key standalone financial information of the Company is as under:

				Million
	QUARTER ENDED		YEAR ENDED
PARTICULARS
30.06.2022		30.06.2021	31.03.2022
	(UNAUDITED)		(AUDITED)
Total income from operations	44,362.29		32,199.51	146,494.04
Net profit for the period before tax (after exceptional items)	1,363.51		888.86	3,503.52
Net profit for the period after tax (after exceptional items)	1,043.41		679.24	2,610.64

1. The above is an extract of the detailed format of quarter ended June 30, 2022 financial results filed with the stock exchanges under Regulation 33 and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The full format of the quarter ended June 30, 2022 financial results (Consolidated/Standalone) are available on the stock exchange websites (National Stock Exchange of India Limited (www.nseindia.com) & BSE Limited (www.bseindia.com)) and on the Company's website (www.apollotyres.com).
2. For the other line items referred in Regulation 52(4) of the SEBI (Listing Obligations and Disclosure Requirements) Regula- tions, 2015, pertinent disclosures have been made to the National Stock Exchange of India Limited (www.nseindia.com) & BSE Limited (www.bseindia.com) and can be accessed on Company's website (www.apollotyres.com).

APOLLO TYRES LTD		For and on behalf of the Board of Directors of
		Apollo Tyres Ltd
CIN: L25111KL1972PLC002449
Regd. Office: 3rd Floor, Areekal Mansion, Near Manorama
Junction, Panampilly Nagar, Kochi 682036, Kerala, India		Sd/-
Corporate Office: Apollo House, 7 Institutional Area,
Sector 32, Gurugram 122001, India.
Tel.: [phone], Fax: [phone]	Place: Gurugram	ONKAR KANWAR
Email: [e-mail], www.apollotyres.com	Date: August 12, 2022	CHAIRMAN & MANAGING DIRECTOR

		13	2022 9

C			. ÄC≤B		^'êqT
ø±		eT+~		..
^'êqT			.	á	n_	.
	á		.		eT+~
	ùd n#êÃ	^'êqT	25 ì$TcÕ	^'êqT $ì
bÕ≥T	. C			.

=	eTTK´eT+Á‹ ..?

• e÷J

				á
	e÷J			.
			@sêŒ≥T
	n_	.		ñqï
kÕ-	.			n_
	sêJHêe÷		.	eTTK´eT+Á‹>±
O+&Ü*‡q	..
	.	ÁbÕC	.
ÁbÕC	˙{≤ eTTì-			ÁbÕC
.100	ÁbÕC
		.	Á>±eT+˝À
	.10
		nì	.
sêJHêe÷'√				ñqï
'êqT	bÕ≥T eTs√ 12		.

e∫à ùde

• XÊK

ñqï	.
nì	.
	21q
	ôVA+ eT+Á‹	cÕ
	.
	bÕ˝≤«sTT
	.

		:
		.
C≤Ø	.	XÊK
ø±C≤	C	.
		.

	...
B+'√		.
nsTT´+~. B+'√ Ä		.
		kÕe÷Á-,
	.
....	C	ñqï
á
.	á

qT+∫ á

.